$1.79
-0.14-7.25%
Last update: Nov 12, 7:36 AM
Ernexa Therapeutics Inc
ERNANASDAQ
Ernexa Therapeutics fell 95.2% from $40.25 to $1.93, behind the S&P 500's +10.8%. Its worst day was Feb 6 (−44.7%), and its low came Nov 5 at $1.83.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Ernexa Therapeutics shares fell 44.7%, while the S&P 500 rose 1.9%.
−44.7%, the year's worst day · S&P 500 +1.9%
Story events cover the past 12 months · Times ET
EPS of $-4.50 was reported on $0.00 revenue.
−4.1% · S&P 500 +0.3%
EPS of $-6.95 was reported on $0.00 revenue.
+66.6%, the year's best day · S&P 500 −0.2%
EPS of $-3.40 missed the $-3.30 estimate on $0.00 revenue.
−3.4% · S&P 500 +0.6%
EPS of $-1.89 beat the $-3.84 estimate on $0.00 revenue.
+4.4% · S&P 500 +2.4%
Where it ended: a close of $1.93 on Nov 11, 2026.
Nothing in the past 12 months.
All ERNA dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ERNA and SPY from Benzinga historical bars. Not investment advice.
